Looking for a comprehensive resource on cervical cancer? CDC’s fact sheet explains cervical cancer in plain language to help everyone understand screening and risk factors. In addition, CDC’s cervical cancer awareness resources are available here and HPV vaccination resources are available here.
The National HPV Vaccination RoundTable Late 2016 brought exciting developments for HPV cancer prevention, with the ACIP recommending an updated 2-dose HPV vaccination schedule. This news was well received by members of the National HPV Vaccination Roundtable, ...
News Category: Global
Looking for a comprehensive resource on cervical cancer? CDC’s fact sheet explains cervical cancer in plain language to help everyone understand screening and risk factors. In addition, CDC’s cervical cancer awareness resources are available here and HPV vaccination resources are available here.
News Category: Global, Uncategorized
The Harvard T.H. Chan School of Public Health published new findings in Journal of the National Cancer Institute in August indicating that women who received the HPV vaccine do not need to be screened for cervical cancer as often as previously recommended. Current national US screening guidelines do not differentiate between women who received HPV vaccination and those who did not. The research evaluated women who received either the bivalent or quadrivalent vaccines at the recommended ages of 11 or ...
News Category: National
Researchers from Yale University have developed a new model to account for HPV transmission and cervical cancer progression to determine that widespread, coordinated use of nonavalent HPV vaccination would provide the same health benefits at the same or lower cost. The study, published in Proceedings of the National Academy of Science in March, found that nonavalent vaccination could decrease cervical cancer incidence by 73%, compared to a 63% reduction in incidence from earlier generation HPV vaccines. The greatest health benefits ...
News Category: Global
In June, Cervical Cancer Free Coalition submitted a written testimony to Congress in support of cervical cancer activities. Read the full testimony here: Testimony for Senate SFOPS from CCFC!
Using data from National Health and Nutrition Examination Survey (NHANES), researchers from the Center for Disease Control and Prevention (CDC) compared HPV prevalence from the pre-vaccine era and 4 years during the vaccine era. Researchers have found a 64% decrease in prevalence of HPV types 16, 18, 6, and 11 among women ages 14 to 19, and a 34% decrease among women ages 20-24. The U.S. News and World Report article can be read here, and the journal article, ...
News Category: National
The results of a study of 1,180 13-26 year old Cincinnati women provide evidence of herd immunity as a result of HPV vaccination. Their observational study, published in Clinical Infectious Diseases in October, note a greater than 30% decrease in prevalence of HPV among unvaccinated women. Researchers compared women before widespread vaccination was introduced, and then 3 and 7 years after vaccine introduction. The news article about the study can be read here, and the full study can be ...
News Category: National
A recent systematic review published in Lancet Global Health in July found global disparities in age-specific vaccination coverage rates between 2006 and 2014. Among the 118 million women targeted for HPV vaccination programs, only 1% were from low or low-middle income countries. More women 10-20 years old received the full vaccine course in developed regions (33.6%) than less developed regions (2.7%). The high cost of the vaccine and programmatic issues were major obstacles to introducing the vaccine in less developed ...
News Category: Global
Researchers from the Center of Disease Control and Prevention (CDC) observed an increase in HPV vaccine coverage for both boys and girls ages 13-17 years old. The finding, published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) in August 2016, noted that the percent of boys 13-17 years old who received at least 1 dose of the HPV vaccine increased 8% between 2014 and 2015. Vaccination also increased by 2.8% among girls 13-17 years old, during that same timeframe. ...
News Category: Global
The American Society of Clinical Oncology (ASCO) recently convened a multidisciplinary panel of health care and patient advocacy experts to provide evidence-based recommendations on secondary prevention of cervical cancer around the world. Their report, entitled “Secondary Prevention of Cervical Cancer: Resource-Stratified Clinical Practice Guideline”, was published in the Journal of Global Oncology in October 2016. The guidelines cover recommended age ranges for and frequency of testing, methods of testing, treatment options, and screening practices in four resource settings: maximal, ...
News Category: Global